Abstract
Abstract: Introduction: Fungal infections are growing more rapidly and becoming a public health concern worldwide. The use of herbal medicines is now increasing due to their many functional properties with fewer side effects. Emblica officinalis, an important medicinal plant, exhibits many therapeutic properties. Method: In this article, the active phytoconstituents of Emblica officinalis were explored for their multitargeting activity as anti-inflammatory and antifungal by computational analysis. Results: A total of nine phytoconstituents including 3,6-di-Ogalloyl- D-glucose, Mucic acid-1,4-lactone-2-O-gallate, Mucic acid-1,4-lactone-5-O-gallate, Mucic acid-1,4-lactone-3-O-gallate, Mucic acid-1,4-lactone-3,5-di-O-gallate, 2,6-dimethoxy-4- (2-hydroxyethyl)phenol-1-O-beta-D-glucopyranoside, Apigenin-7-O-(6'-butyryl-beta-glucopyranoside), S-eriodictoyl-7-O-(6'-O-trans-p-coumaryl)-beta-D-glucopyranoside, and 1,2,3,4,6- penta-O-galloyl glucose showed better results as compared to standard drugs taken in the study. Conclusion: Further, these constituents indicated good ADME properties during the SwissADME online analysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
